Abstract:Background Cancer is a heterogeneous disease caused by genomic aberrations and characterized by significant variability in clinical outcomes and response to therapies. Several subtypes of common cancers have been identified based on alterations of individual cancer genes, such as HER2, EGFR, and others. However, cancer is a complex disease driven by the interaction of multiple genes, so the copy number status of individual genes is not sufficient to define cancer subtypes and predict responses to treatments. A classification based on genome-wide copy number patterns would be better suited for this purpose. Method To develop a more comprehensive cancer taxonomy based on genome-wide patterns of copy number abnormalities, we designed an unsupervised classification algorithm that identifies genomic subgroups of tumors. This algorithm is based on a modified genomic Non-negative Matrix Factorization (gNMF) algorithm and includes several additional components, namely a pilot hierarchical clustering procedure to determine the number of clusters, a multiple random initiation scheme, a new stop criterion for the core gNMF, as well as a 10-fold cross-validation stability test for quality assessment. Result We applied our algorithm to identify genomic subgroups of three major cancer types: non-small cell lung carcinoma (NSCLC), colorectal cancer (CRC), and malignant melanoma. High-density SNP array datasets for patient tumors and established cell lines were used to define genomic subclasses of the diseases and identify cell lines representative of each genomic subtype. The algorithm was compared with several traditional clustering methods and showed improved performance. To validate our genomic taxonomy of NSCLC, we correlated the genomic classification with disease outcomes. Overall survival time and time to recurrence were shown to differ significantly between the genomic subtypes. Conclusions We developed an algorithm for cancer classification based on genome-wide patterns of copy number aberrations and demonstrated its superiority to existing clustering methods. The algorithm was applied to define genomic subgroups of three cancer types and identify cell lines representative of these subgroups. Our data enabled the assembly of representative cell line panels for testing drug candidates.

Identification of cancer genes using a statistical framework for multi-experiment analysis of non-discretized array CGH data (vol 36, pg 13, 2008)

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

Combining chromosomal arm status and significantly aberrant genomic locations reveals new cancer subtypes

Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression

High-Resolution Genomic And Expression Analyses Of Copy Number Alterations In Breast Tumors

Functional Genomic Analysis of Chromosomal Aberrations in a Compendium of 8000 Cancer Genomes

The landscape of somatic copy-number alteration across human cancers

The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers.

Cross-species Comparison of Acgh Data from Mouse and Human BRCA1- and BRCA2-mutated Breast Cancers

Genome-Wide Identification of Somatic Aberrations from Paired Normal-Tumor Samples

Array Comparative Genome Hybridization for Tumor Classification and Gene Discovery in Mouse Models of Malignant Melanoma.

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

GPHMM: an Integrated Hidden Markov Model for Identification of Copy Number Alteration and Loss of Heterozygosity in Complex Tumor Samples Using Whole Genome SNP Arrays

Genome-wide Identification of Significant Aberrations in Cancer Genome

Cancer Sample Analysis Utilizing Single-Nucleotide Polymorphism Array and Array Comparative Genomic Hybridization

Copy Number Analysis Of Whole-Genome Data Using Bic-Seq2 And Its Application To Detection Of Cancer Susceptibility Variants

TAGCNA: A Method to Identify Significant Consensus Events of Copy Number Alterations in Cancer

Discrimination of Recurrent CNVs from Individual Ones from Multisample Acgh by Jointly Constrained Minimization

Genetic Determinants of the Molecular Portraits of Epithelial Cancers

An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models